{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:14:03Z","timestamp":1786119243246,"version":"build-2736575974"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,6]]},"DOI":"10.7759\/cureus.114070","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:45:53Z","timestamp":1786038353000},"source":"Crossref","is-referenced-by-count":0,"title":["Impact of Loading Doses of Direct Oral Anticoagulants on Left Ventricular and Left Atrial Thrombus: The LOAD-LVT Study"],"prefix":"10.7759","author":[{"given":"Kyle G","family":"Fischer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaynab","family":"Omisade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratham","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Gorski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan J","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001092","article-title":"Management of patients at risk for and with left ventricular thrombus: a scientific statement from the American Heart Association","volume":"146","author":"Levine GN","year":"2022","unstructured":"Levine GN, McEvoy JW, Fang JC, et al.. Management of patients at risk for and with left ventricular thrombus: a scientific statement from the American Heart Association. Circulation. 2022, 146:e205-23. 10.1161\/CIR.0000000000001092","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e3182742cf6","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"127","author":"O'Gara PT","year":"2013","unstructured":"O'Gara PT, Kushner FG, Ascheim DD, et al.. 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation. 2013, 127:e362-425. 10.1161\/CIR.0b013e3182742cf6","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan WN","year":"2014","unstructured":"Kernan WN, Ovbiagele B, Black HR, et al.. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2014, 45:2160-236. 10.1161\/STR.0000000000000024","journal-title":"Stroke"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)","volume":"39","author":"Ibanez B","year":"2018","unstructured":"Ibanez B, James S, Agewall S, et al.. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018, 39:119-77. 10.1093\/eurheartj\/ehx393","journal-title":"Eur Heart J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13010158","article-title":"Direct oral anticoagulants for stroke and systemic embolism prevention in patients with left ventricular thrombus","volume":"13","author":"Badescu MC","year":"2023","unstructured":"Badescu MC, Sorodoc V, Lionte C, et al.. Direct oral anticoagulants for stroke and systemic embolism prevention in patients with left ventricular thrombus. J Pers Med. 2023, 13:158. 10.3390\/jpm13010158","journal-title":"J Pers Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.14084","article-title":"Systematic review of efficacy of direct oral anticoagulants and vitamin K antagonists in left ventricular thrombus","volume":"9","author":"Huang L","year":"2022","unstructured":"Huang L, Tan Y, Pan Y. Systematic review of efficacy of direct oral anticoagulants and vitamin K antagonists in left ventricular thrombus. ESC Heart Fail. 2022, 9:3519-32. 10.1002\/ehf2.14084","journal-title":"ESC Heart Fail"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.18773\/austprescr.2019.039","article-title":"Venous thromboembolism: current management","volume":"42","author":"Stevens H","year":"2019","unstructured":"Stevens H, Tran H, Gibbs H. Venous thromboembolism: current management. Aust Prescr. 2019, 42:123-6. 10.18773\/austprescr.2019.039","journal-title":"Aust Prescr"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.0652","article-title":"Off-label use of direct oral anticoagulants compared with warfarin for left ventricular thrombi","volume":"5","author":"Robinson AA","year":"2020","unstructured":"Robinson AA, Trankle CR, Eubanks G, et al.. Off-label use of direct oral anticoagulants compared with warfarin for left ventricular thrombi. JAMA Cardiol. 2020, 5:685-92. 10.1001\/jamacardio.2020.0652","journal-title":"JAMA Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd9100351","article-title":"Left atrial appendage thrombosis and oral anticoagulants: a meta-analysis of risk and treatment response","volume":"9","author":"Cheng YY","year":"2022","unstructured":"Cheng YY, Tan S, Hong CT, Yang CC, Chan L. Left atrial appendage thrombosis and oral anticoagulants: a meta-analysis of risk and treatment response. J Cardiovasc Dev Dis. 2022, 9:351. 10.3390\/jcdd9100351","journal-title":"J Cardiovasc Dev Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.01.049","article-title":"Comparative study of oral anticoagulation in left ventricular thrombi (No-LVT Trial)","volume":"77","author":"Abdelnabi M","year":"2021","unstructured":"Abdelnabi M, Saleh Y, Fareed A, et al.. Comparative study of oral anticoagulation in left ventricular thrombi (No-LVT Trial). J Am Coll Cardiol. 2021, 77:1590-2. 10.1016\/j.jacc.2021.01.049","journal-title":"J Am Coll Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvaa096","article-title":"The use of novel oral anticoagulants compared to vitamin K antagonists (warfarin) in patients with left ventricular thrombus after acute myocardial infarction","volume":"7","author":"Jones DA","year":"2021","unstructured":"Jones DA, Wright P, Alizadeh MA, et al.. The use of novel oral anticoagulants compared to vitamin K antagonists (warfarin) in patients with left ventricular thrombus after acute myocardial infarction. Eur Heart J Cardiovasc Pharmacother. 2021, 7:398-404. 10.1093\/ehjcvp\/pvaa096","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2016.05.007","article-title":"Left atrial thrombus resolution in atrial fibrillation or flutter: results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF)","volume":"178","author":"Lip GY","year":"2016","unstructured":"Lip GY, Hammerstingl C, Marin F, et al.. Left atrial thrombus resolution in atrial fibrillation or flutter: results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF). Am Heart J. 2016, 178:126-34. 10.1016\/j.ahj.2016.05.007","journal-title":"Am Heart J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2025.102243","article-title":"Direct oral anticoagulants or warfarin for left ventricular thrombus: a meta-analysis of randomized clinical trials","volume":"4","author":"Koeckerling D","year":"2025","unstructured":"Koeckerling D, Reddy RK, Barker J, et al.. Direct oral anticoagulants or warfarin for left ventricular thrombus: a meta-analysis of randomized clinical trials. JACC Adv. 2025, 4:102243. 10.1016\/j.jacadv.2025.102243","journal-title":"JACC Adv"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/511194-impact-of-loading-doses-of-direct-oral-anticoagulants-on-left-ventricular-and-left-atrial-thrombus-the-load-lvt-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:45:54Z","timestamp":1786038354000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/511194-impact-of-loading-doses-of-direct-oral-anticoagulants-on-left-ventricular-and-left-atrial-thrombus-the-load-lvt-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.114070","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,6]]}}}